The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice

Disease progression in amyotrophic lateral sclerosis (ALS) is characterized by degeneration of motoneurons and their axons which results in a progressive muscle weakness and ultimately death from respiratory failure. The only approved drug, riluzole, lacks clinical efficacy so that more potent treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Günther, René, Saal, Kim-Ann, Suhr, Martin, Scheer, David, Koch, Jan Christoph, Bähr, Mathias, Lingor, Paul, Tönges, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187656/
https://www.ncbi.nlm.nih.gov/pubmed/25339858
http://dx.doi.org/10.3389/fnins.2014.00304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187656/
https://www.ncbi.nlm.nih.gov/pubmed/25339858
http://dx.doi.org/10.3389/fnins.2014.00304

Ejemplares similares